{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Gastroenterology", "Herbal therapy", "Inflammation and oxidative stress", "Irritable bowel syndrome", "Mechanism", "Polyphenols"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31273572", "DateCompleted": {"Year": "2020", "Month": "04", "Day": "09"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "07", "Day": "04"}], "Language": ["eng"], "ELocationID": ["10.1007/s40199-019-00284-1"], "Journal": {"ISSN": "2008-2231", "JournalIssue": {"Volume": "27", "Issue": "2", "PubDate": {"Year": "2019", "Month": "Dec"}}, "Title": "Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences", "ISOAbbreviation": "Daru"}, "ArticleTitle": "Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review.", "Pagination": {"StartPage": "755", "EndPage": "780", "MedlinePgn": "755-780"}, "Abstract": {"AbstractText": ["Irritable bowel syndrome (IBS) is a well diagnosed disease, thoroughly attributed to series of symptoms criteria that embrace a broad range of abdominal complainers. Such criteria help to diagnosis the disease and can guide controlled clinical trials to seek new therapeutic agents. Accordingly, a verity of mechanisms and pathophysiological conditions including inflammation, oxidative stress, lipid peroxidation and different life styles are involved in IBS. Predictably, diverse therapeutic approaches are available and prescribed by clinicians due to major manifestations (i.e., diarrhea-predominance, constipation-predominance, abdominal pain and visceral hypersensitivity), psychological disturbances, and patient preferences between herbal treatments versus pharmacological therapies, dietary or microbiological approaches. Herein, we gathered the latest scientific data between 1973 and 2019 from databases such as PubMed, Google Scholar, Scopus and Cochrane library on relevant studies concerning beneficial effects of herbal treatments for IBS, in particular polyphenols. This is concluded that polyphenols might be applicable for preventing IBS and improving the IBS symptoms, mainly through suppressing the inflammatory signaling pathways, which nowadays are known as novel platform for the IBS management. Graphical abstract."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran."}], "LastName": "Roudsari", "ForeName": "Nazanin Momeni", "Initials": "NM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran."}], "LastName": "Lashgari", "ForeName": "Naser-Aldin", "Initials": "NA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. mh.farzaei@gmail.com."}, {"Identifier": [], "Affiliation": "Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. mh.farzaei@gmail.com."}], "LastName": "Farzaei", "ForeName": "Mohammad Hosein", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Oswaldo Cruz Foundation (FIOCRUZ), Institute of Technology in Pharmaceuticals (Farmanguinhos), Rio de Janeiro, RJ, Brazil."}], "LastName": "Marques", "ForeName": "Andr\u00e9 M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran. amirhosein172@hotmail.com."}, {"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran. amirhosein172@hotmail.com."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran. amirhosein172@hotmail.com."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran. amirhosein172@hotmail.com."}, {"Identifier": [], "Affiliation": "Gastrointestinal Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran. amirhosein172@hotmail.com."}], "LastName": "Abdolghaffari", "ForeName": "Amir Hossein", "Initials": "AH"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Daru", "NlmUniqueID": "101125969", "ISSNLinking": "1560-8115"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Polyphenols"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Clinical Trials as Topic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "prevention & control"], "DescriptorName": "Irritable Bowel Syndrome"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Polyphenols"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Wessely S, White PD. There is only one functional somatic syndrome. Br J Psychiatry. 2004;185(2):95\u201396.", "ArticleIdList": ["15286058"]}, {"Citation": "Mayer EA. Irritable bowel syndrome. N Engl J Med. 2008;358(16):1692\u20131699.", "ArticleIdList": ["PMC3816529", "18420501"]}, {"Citation": "Spiegel B, et al. Predictors of patient-assessed illness severity in irritable bowel syndrome. Am J Gastroenterol. 2008;103(10):2536.", "ArticleIdList": ["PMC2949074", "18637089"]}, {"Citation": "Trinkley KE, Nahata MC. Treatment of irritable bowel syndrome. J Clin Pharm Ther. 2011;36(3):275\u2013282.", "ArticleIdList": ["21545610"]}, {"Citation": "Longstreth GF, et al. Functional bowel disorders. Gastroenterology. 2006;130(5):1480\u20131491.", "ArticleIdList": ["16678561"]}, {"Citation": "Spiegel BM, et al. Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol. 2010;105(4):848.", "ArticleIdList": ["PMC2887205", "20197761"]}, {"Citation": "Mearin F, Lacy BE. Diagnostic criteria in IBS: useful or not? Neurogastroenterol Motil. 2012;24(9):791\u2013801.", "ArticleIdList": ["22908861"]}, {"Citation": "Whitehead WE, Drossman DA. Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review. Am J Gastroenterol. 2010;105(4):814.", "ArticleIdList": ["PMC3856202", "20179688"]}, {"Citation": "Whitehead W, et al. Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome. Aliment Pharmacol Ther. 2006;24(1):137\u2013146.", "ArticleIdList": ["16803612"]}, {"Citation": "Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014;6:71\u201380.", "ArticleIdList": ["PMC3921083", "24523597"]}, {"Citation": "Lovell Rebecca M., Ford Alexander C. Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis. Clinical Gastroenterology and Hepatology. 2012;10(7):712-721.e4.", "ArticleIdList": ["22426087"]}, {"Citation": "Pauls R, Max J. Symptoms and dietary practices of irritable bowel syndrome patients compared to controls: results of a USA national survey. Minerva Gastroenterol Dietol. 2019;65(1):1\u201310.", "ArticleIdList": ["30293415"]}, {"Citation": "Jones MP, et al. Development and initial validation of a measure of perceived stigma in irritable bowel syndrome. Psychol Health Med. 2009;14(3):367\u2013374.", "ArticleIdList": ["19444714"]}, {"Citation": "Dancey C, et al. Perceived stigma, illness intrusiveness and quality of life in men and women with irritable bowel syndrome. Psychol Health Med. 2002;7(4):381\u2013395."}, {"Citation": "Nettleton S. \u2018I just want permission to be ill\u2019: towards a sociology of medically unexplained symptoms. Soc Sci Med. 2006;62(5):1167\u20131178.", "ArticleIdList": ["16135395"]}, {"Citation": "Farmer J, et al. Rural/urban differences in accounts of patients\u2019 initial decisions to consult primary care. Health Place. 2006;12(2):210\u2013221.", "ArticleIdList": ["16338636"]}, {"Citation": "Cummings KM, Becker MH, Maile MC. Bringing the models together: an empirical approach to combining variables used to explain health actions. J Behav Med. 1980;3(2):123\u2013145.", "ArticleIdList": ["7420418"]}, {"Citation": "Zola IK. Pathways to the doctor\u2014from person to patient. Soc Sci Med (1967) 1973;7(9):677\u2013689.", "ArticleIdList": ["4749058"]}, {"Citation": "Cann P, et al. Role of loperamide and placebo in management of irritable bowel syndrome (IBS) Dig Dis Sci. 1984;29(3):239\u2013247.", "ArticleIdList": ["6365490"]}, {"Citation": "Efskind P, Bernklev T, Vatn M. A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome. Scand J Gastroenterol. 1996;31(5):463\u2013468.", "ArticleIdList": ["8734343"]}, {"Citation": "Pasricha PJ. Desperately seeking serotonin\u2026 a commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders. Gastroenterology. 2007;132(7):2287\u20132290.", "ArticleIdList": ["17570201"]}, {"Citation": "Abbas Z, et al. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial. Eur J Gastroenterol Hepatol. 2014;26(6):630\u2013639.", "ArticleIdList": ["24722560"]}, {"Citation": "Trinkley KE, Nahata MC. Medication management of irritable bowel syndrome. Digestion. 2014;89(4):253\u2013267.", "ArticleIdList": ["24992947"]}, {"Citation": "Ku\u0142ak-Bejda A, Bejda G, Waszkiewicz N. Antidepressants for irritable bowel syndrome\u2014a systematic review. Pharmacol Rep. 2017;69(6):1366\u20131379.", "ArticleIdList": ["29132094"]}, {"Citation": "Clouse R. Antidepressants for irritable bowel syndrome. Gut. 2003;52(4):598\u2013599.", "ArticleIdList": ["PMC1773590", "12631677"]}, {"Citation": "Nee J, Zakari M, Lembo AJ. Novel therapies in IBS-D treatment. Curr Treat Options Gastroenterol. 2015;13(4):432\u2013440.", "ArticleIdList": ["26432092"]}, {"Citation": "Lee K, Kim J, Cho S. Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2005;22(10):981\u2013988.", "ArticleIdList": ["16268973"]}, {"Citation": "Crofford LJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52(4):1264\u20131273.", "ArticleIdList": ["15818684"]}, {"Citation": "Goldenberg DL. Pain/depression dyad: a key to a better understanding and treatment of functional somatic syndromes. Am J Med. 2010;123(8):675\u2013682.", "ArticleIdList": ["20541169"]}, {"Citation": "H\u00e4user W, Petzke F, Sommer C. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain. 2010;11(6):505\u2013521.", "ArticleIdList": ["20418173"]}, {"Citation": "Whorwell PJ, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101(7):1581.", "ArticleIdList": ["16863564"]}, {"Citation": "Enck P, et al. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo. Z Gastroenterol. 2009;47(2):209.", "ArticleIdList": ["19197823"]}, {"Citation": "Drouault-Holowacz S, et al. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol. 2008;32(2):147\u2013152.", "ArticleIdList": ["18387426"]}, {"Citation": "Kajander K, et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther. 2008;27(1):48\u201357.", "ArticleIdList": ["17919270"]}, {"Citation": "O\u2019Mahony L, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128(3):541\u2013551.", "ArticleIdList": ["15765388"]}, {"Citation": "Cappello G, et al. Peppermint oil (Mintoil\u00ae) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. Dig Liver Dis. 2007;39(6):530\u2013536.", "ArticleIdList": ["17420159"]}, {"Citation": "Liu J-H, et al. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol. 1997;32(6):765.", "ArticleIdList": ["9430014"]}, {"Citation": "Evans M, Wotring R. Polyphenol-reactive oxygen species compositions and methods. United States\u00a0Patent Application 16/143,398."}, {"Citation": "Salah N, et al. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys. 1995;322(2):339\u2013346.", "ArticleIdList": ["7574706"]}, {"Citation": "Pastoriza S, et al. Healthy properties of green and white teas: an update. Food Funct. 2017;8(8):2650\u20132662.", "ArticleIdList": ["28640307"]}, {"Citation": "Park S-J, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell. 2012;148(3):421\u2013433.", "ArticleIdList": ["PMC3431801", "22304913"]}, {"Citation": "Ray Nancy B., Hilsabeck Kyle D., Karagiannis Tom C., McCord D. Elizabeth. The Role of Functional Food Security in Global Health. 2019. Bioactive Olive Oil Polyphenols in the Promotion of Health; pp. 623\u2013637."}, {"Citation": "Igwe EO, et al. A systematic literature review of the effect of anthocyanins on gut microbiota populations. J Hum Nutr Diet. 2019;32(1):53\u201362.", "ArticleIdList": ["29984532"]}, {"Citation": "Talbott SM, et al. Effect of coordinated probiotic/prebiotic/phytobiotic supplementation on microbiome balance and psychological mood state in healthy stressed adults. Funct Foods Health Dis. 2019;9(4):265\u2013275."}, {"Citation": "Nelkowska DD. Importance of personal resources for the quality of life of patients with irritable bowel syndrome (IBS). Journal of Education, Health and Sport. 2019;9(4):442\u201353."}, {"Citation": "Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Med Cell Longev. 2009;2(5):270\u2013278.", "ArticleIdList": ["PMC2835915", "20716914"]}, {"Citation": "Kondratyuk TP, Pezzuto JM. Natural product polyphenols of relevance to human health. Pharm Biol. 2004;42(sup1):46\u201363."}, {"Citation": "Scalbert A, et al. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr. 2005;45(4):287\u2013306.", "ArticleIdList": ["16047496"]}, {"Citation": "Vitrac X, et al. Direct liquid chromatographic analysis of resveratrol derivatives and flavanonols in wines with absorbance and fluorescence detection. Anal Chim Acta. 2002;458(1):103\u2013110."}, {"Citation": "Barahona Maria J, Baratta Vanessa, Ollodart Jenna, Mulligan David, Geibel John P. Design and implementation of novel nutraceuticals and derivatives for treating intestinal disorders. Future Medicinal Chemistry. 2019;11(8):847\u2013855.", "ArticleIdList": ["PMC8008207", "30994367"]}, {"Citation": "Spencer JP, et al. Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr. 2008;99(1):12\u201322.", "ArticleIdList": ["17666146"]}, {"Citation": "Luqman S, Rizvi SI. Protection of lipid peroxidation and carbonyl formation in proteins by capsaicin in human erythrocytes subjected to oxidative stress. Phytother Res. 2006;20(4):303\u2013306.", "ArticleIdList": ["16557614"]}, {"Citation": "Pandey KB, Rizvi SI. Protective effect of resveratrol on markers of oxidative stress in human erythrocytes subjected to in vitro oxidative insult. Phytother Res. 2010;24(S1):S11\u2013S14.", "ArticleIdList": ["19441064"]}, {"Citation": "Pandey KB, Mishra N, Rizvi SI. Protective role of myricetin on markers of oxidative stress in human erythrocytes subjected to oxidative stress. Nat Prod Commun. 2009;4(2):221\u2013226.", "ArticleIdList": ["19370927"]}, {"Citation": "Prade RA, et al. Pectins, pectinases and plant-microbe interactions. Biotechnol Genet Eng Rev. 1999;16(1):361\u2013392.", "ArticleIdList": ["10819085"]}, {"Citation": "Sinagra E, et al. Inflammation in irritable bowel syndrome: myth or new treatment target? World J Gastroenterol. 2016;22(7):2242.", "ArticleIdList": ["PMC4734999", "26900287"]}, {"Citation": "Choghakhori R, et al. Inflammatory cytokines and oxidative stress biomarkers in irritable bowel syndrome: association with digestive symptoms and quality of life. Cytokine. 2017;93:34\u201343.", "ArticleIdList": ["28506572"]}, {"Citation": "Kamatou GP, et al. Menthol: a simple monoterpene with remarkable biological properties. Phytochemistry. 2013;96:15\u201325.", "ArticleIdList": ["24054028"]}, {"Citation": "Yu F-Y, et al. Effects of baicalin in CD4+ CD29+ T cell subsets of ulcerative colitis patients. World J Gastroenterol. 2014;20(41):15299.", "ArticleIdList": ["PMC4223263", "25386078"]}, {"Citation": "Scully P, et al. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol. 2010;105(10):2235.", "ArticleIdList": ["20407431"]}, {"Citation": "Schuhmacher A, Reichling J, Schnitzler P. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro. Phytomedicine. 2003;10(6/7):504.", "ArticleIdList": ["13678235"]}, {"Citation": "Schmulson M, et al. Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico. Am J Gastroenterol. 2012;107(5):747.", "ArticleIdList": ["22270083"]}, {"Citation": "Collins S, Piche T, Rampal P. The putative role of inflammation in the irritable bowel syndrome. Gut. 2001;49(6):743\u2013745.", "ArticleIdList": ["PMC1728553", "11709500"]}, {"Citation": "Spiller R, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007;56(12):1770\u20131798.", "ArticleIdList": ["PMC2095723", "17488783"]}, {"Citation": "Hong SW, et al. Aloe vera is effective and safe in short-term treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Neurogastroenterol Motil. 2018;24(4):528\u2013535.", "ArticleIdList": ["PMC6175553", "30153721"]}, {"Citation": "Hughes PA, et al. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes. Gut. 2013;62(10):1456\u20131465.", "ArticleIdList": ["22767422"]}, {"Citation": "Kline RM, et al. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr. 2001;138(1):125\u2013128.", "ArticleIdList": ["11148527"]}, {"Citation": "Bundy R, et al. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. J Altern Complement Med. 2004;10(6):1015\u20131018.", "ArticleIdList": ["15673996"]}, {"Citation": "Ford AC, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ. 2008;337:a2313.", "ArticleIdList": ["PMC2583392", "19008265"]}, {"Citation": "Alt F, et al. Evaluation of benefit and tolerability of IQP-CL-101 (Xanthofen) in the symptomatic improvement of irritable bowel syndrome: a double-blinded, randomised, Placebo-Controlled Clinical Trial. Phytother Res. 2017;31(7):1056\u20131062.", "ArticleIdList": ["PMC5518189", "28508427"]}, {"Citation": "McIntosh, K., et al., FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut. 2016: p. gutjnl-2015-311339.", "ArticleIdList": ["26976734"]}, {"Citation": "Jalili M, et al. Co-Administration of soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease. PLoS One. 2016;11(8):e0158545.", "ArticleIdList": ["PMC4973900", "27490103"]}, {"Citation": "L\u00f3pez A, et al. Phenolic constituents, antioxidant and preliminary antimycoplasmic activities of leaf skin and flowers of Aloe vera (L.) Burm. f.(syn. A. barbadensis mill.) from the Canary Islands (Spain) Molecules. 2013;18(5):4942\u20134954.", "ArticleIdList": ["PMC6270129", "23624648"]}, {"Citation": "Portincasa P, et al. Curcumin and fennel essential oil improve symptoms and quality of life in patients with irritable bowel syndrome. J Gastrointest Liver Dis. 2016:25(2).", "ArticleIdList": ["27308645"]}, {"Citation": "Merat S, et al. The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome. Dig Dis Sci. 2010;55(5):1385\u20131390.", "ArticleIdList": ["19507027"]}, {"Citation": "Davis K, et al. Randomised double-blind placebo-controlled trial of aloe vera for irritable bowel syndrome. Int J Clin Pract. 2006;60(9):1080\u20131086.", "ArticleIdList": ["16749917"]}, {"Citation": "V\u00e1zquez B, et al. Antiinflammatory activity of extracts from Aloe vera gel. J Ethnopharmacol. 1996;55(1):69\u201375.", "ArticleIdList": ["9121170"]}, {"Citation": "Vaziri ND, Rodr\u00edguez-Iturbe B. Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat Rev Nephrol. 2006;2(10):582.", "ArticleIdList": ["17003837"]}, {"Citation": "Langmead L, et al. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther. 2004;19(7):739\u2013747.", "ArticleIdList": ["15043514"]}, {"Citation": "Agarwal O. Prevention of atheromatous heart disease. Angiology. 1985;36(8):485\u2013492.", "ArticleIdList": ["2864002"]}, {"Citation": "Mete R, et al. The role of oxidants and reactive nitrogen species in irritable bowel syndrome: a potential etiological explanation. Med Sci Monit. 2013;19:762.", "ArticleIdList": ["PMC3781198", "24029778"]}, {"Citation": "Yeh GY, et al. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 2003;26(4):1277\u20131294.", "ArticleIdList": ["12663610"]}, {"Citation": "Klein AD, Penneys NS. Aloe vera. J Am Acad Dermatol. 1988;18(4):714\u2013720.", "ArticleIdList": ["3286692"]}, {"Citation": "Choi SW, et al. The wound-healing effect of a glycoprotein fraction isolated from aloe vera. Br J Dermatol. 2001;145(4):535\u2013545.", "ArticleIdList": ["11703278"]}, {"Citation": "Eamlamnam K, et al. Effects of Aloe vera and sucralfate on gastric microcirculatory changes, cytokine levels and gastric ulcer healing in rats. World J Gastroenterol: WJG. 2006;12(13):2034.", "ArticleIdList": ["PMC4087681", "16610053"]}, {"Citation": "Werawatganon D, et al. Aloe vera attenuated gastric injury on indomethacin-induced gastropathy in rats. World J Gastroenterol: WJG. 2014;20(48):18330.", "ArticleIdList": ["PMC4277969", "25561799"]}, {"Citation": "Hutchings, H., et al., A randomised, cross-over, placebo-controlled study of Aloe vera in patients with irritable bowel syndrome: effects on patient quality of life. ISRN Gastroenterol, 2010. 2011.", "ArticleIdList": ["PMC3168391", "21991499"]}, {"Citation": "St\u00f8rsrud S, Pont\u00e9n I, Simr\u00e9n M. A pilot study of the effect of Aloe barbadensis mill. extract (AVH200\u00ae) in patients with irritable bowel syndrome: a randomized, double-blind, placebo-controlled study. J Gastrointestin Liver Dis. 2015;24(3):275\u2013280.", "ArticleIdList": ["26405698"]}, {"Citation": "Ndhlala A, et al. Antimicrobial, anti-inflammatory and mutagenic investigation of the south African tree aloe (Aloe barberae) J Ethnopharmacol. 2009;124(3):404\u2013408.", "ArticleIdList": ["19505552"]}, {"Citation": "Athiban PP, et al. Evaluation of antimicrobial efficacy of Aloe vera and its effectiveness in decontaminating gutta percha cones. J Conserv Dent. 2012;15(3):246.", "ArticleIdList": ["PMC3410334", "22876011"]}, {"Citation": "Arunkumar S, Muthuselvam M. Analysis of phytochemical constituents and antimicrobial activities of Aloe vera L. against clinical pathogens. World J Agric Sci. 2009;5(5):572\u2013576."}, {"Citation": "Philip J, John S, Iyer P. Antimicrobial activity of aloevera barbedensis, daucus carota, emblica officinalis, honey and punica granatum and formulation of a health drink and salad. Malays J Microbiol. 2012;8(3):141\u2013147p."}, {"Citation": "Alemdar S, Agaoglu S. Investigation of in vitro antimicrobial activity of Aloe vera juice. J Anim Vet Adv. 2009;8(1):99\u2013102."}, {"Citation": "Cock IE. Antimicrobial activity of Aloe barbadensis miller leaf gel components. Internet J Microbiol. 2008;4(2):17."}, {"Citation": "Hu Y, Xu J, Hu Q. Evaluation of antioxidant potential of Aloe vera (Aloe barbadensis miller) extracts. J Agric Food Chem. 2003;51(26):7788\u20137791.", "ArticleIdList": ["14664546"]}, {"Citation": "Fani M, Kohanteb J. Inhibitory activity of Aloe vera gel on some clinically isolated cariogenic and periodontopathic bacteria. J Oral Sci. 2012;54(1):15\u201321.", "ArticleIdList": ["22466882"]}, {"Citation": "Mart\u00ednez C, et al. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Am J Gastroenterol. 2012;107(5):736.", "ArticleIdList": ["22415197"]}, {"Citation": "Ceriello A, et al. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia. 2001;44(7):834\u2013838.", "ArticleIdList": ["11508267"]}, {"Citation": "Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615\u20131625.", "ArticleIdList": ["15919781"]}, {"Citation": "Shyur L-F, et al. Antioxidant properties of extracts from medicinal plants popularly used in Taiwan. Int J Appl Sci Eng. 2005;3(3):195\u2013202."}, {"Citation": "Langmead L, Makins R, Rampton D. Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro. Aliment Pharmacol Ther. 2004;19(5):521\u2013527.", "ArticleIdList": ["14987320"]}, {"Citation": "Yordi, E.G., et al., Antioxidant and pro-oxidant effects of polyphenolic compounds and structure-activity relationship evidence, in Nutrition, well-being and health 2012, InTech."}, {"Citation": "Sparks M, et al. Does peppermint oil relieve spasm during barium enema? Br J Radiol. 1995;68(812):841\u2013843.", "ArticleIdList": ["7551780"]}, {"Citation": "Asao T, et al. Spasmolytic effect of peppermint oil in barium during double-contrast barium enema compared with Buscopan. Clin Radiol. 2003;58(4):301\u2013305.", "ArticleIdList": ["12662951"]}, {"Citation": "May B, et al. Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia. Arzneimittelforschung. 1996;46(12):1149\u20131153.", "ArticleIdList": ["9006790"]}, {"Citation": "G\u00f6bel H, et al. Effectiveness of oleum menthae piperitae and paracetamol in therapy of headache of the tension type. Nervenarzt. 1996;67(8):672\u2013681.", "ArticleIdList": ["8805113"]}, {"Citation": "Yu Y, et al. The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling. Metab Brain Dis. 2015;30(1):47\u201355.", "ArticleIdList": ["24807589"]}, {"Citation": "Xu, Y., et al., trans-Resveratrol Ameliorates Stress-Induced Irritable Bowel Syndrome-Like Behaviors by Regulation of Brain-Gut Axis. Front Pharmacol. 2018. 9.", "ArticleIdList": ["PMC6013570", "29962949"]}, {"Citation": "Mao Q, et al. Chemical profiles and pharmacological activities of Chang-Kang-fang, a multi-herb Chinese medicinal formula, for treating irritable bowel syndrome. J Ethnopharmacol. 2017;201:123\u2013135.", "ArticleIdList": ["28263849"]}, {"Citation": "Micucci M, et al. Newer insights into the antidiarrheal effects of Acacia catechu Willd. Extract in Guinea pig. J Med Food. 2017;20(6):592\u2013600.", "ArticleIdList": ["28422543"]}, {"Citation": "Chen Q, et al. A novel prebiotic blend product prevents irritable bowel syndrome in mice by improving gut microbiota and modulating immune response. Nutrients. 2017;9(12):1341.", "ArticleIdList": ["PMC5748791", "29232851"]}, {"Citation": "Hawthorn M, et al. The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations. Aliment Pharmacol Ther. 1988;2(2):101\u2013118.", "ArticleIdList": ["2856502"]}, {"Citation": "Hills JM, Aaronson PI. The mechanism of action of peppermint oil on gastrointestinal smooth muscle: an analysis using patch clamp electrophysiology and isolated tissue pharmacology in rabbit and Guinea pig. Gastroenterology. 1991;101(1):55\u201365.", "ArticleIdList": ["1646142"]}, {"Citation": "Walstab J, et al. Natural compounds boldine and menthol are antagonists of human 5-HT 3 receptors: implications for treating gastrointestinal disorders. Neurogastroenterol Motil. 2014;26(6):810\u2013820.", "ArticleIdList": ["24708203"]}, {"Citation": "Galeotti N, et al. Menthol: a natural analgesic compound. Neurosci Lett. 2002;322(3):145\u2013148.", "ArticleIdList": ["11897159"]}, {"Citation": "Harries N, James K, Pugh W. Antifoaming and carminative actions of volatile oils. J Clin Pharm Ther. 1977;2(3):171\u2013177."}, {"Citation": "Myers SR, Hawrelak J, Cattley T. Essential oils in the treatment of intestinal dysbiosis: a preliminary in vitro study. Altern Med Rev. 2009;14(4):380\u2013384.", "ArticleIdList": ["20030464"]}, {"Citation": "Juergens U, St\u00f6ber M, Vetter H. The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases. Eur J Med Res. 1998;3(12):539\u2013545.", "ArticleIdList": ["9889172"]}, {"Citation": "Enck P, et al. Therapy options in irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2010;22(12):1402\u20131411.", "ArticleIdList": ["21389791"]}, {"Citation": "Cash BD, Epstein MS, Shah SM. A novel delivery system of peppermint oil is an effective therapy for irritable bowel syndrome symptoms. Dig Dis Sci. 2016;61(2):560\u2013571.", "ArticleIdList": ["PMC4729798", "26319955"]}, {"Citation": "Amato A, Liotta R, Mul\u00e8 F. Effects of menthol on circular smooth muscle of human colon: analysis of the mechanism of action. Eur J Pharmacol. 2014;740:295\u2013301.", "ArticleIdList": ["25046841"]}, {"Citation": "Kim HJ, et al. Menthol modulates pacemaker potentials through TRPA1 channels in cultured interstitial cells of cajal from murine small intestine. Cell Physiol Biochem. 2016;38(5):1869\u20131882.", "ArticleIdList": ["27160463"]}, {"Citation": "Atta A, Alkofahi A. Anti-nociceptive and anti-inflammatory effects of some Jordanian medicinal plant extracts. J Ethnopharmacol. 1998;60(2):117\u2013124.", "ArticleIdList": ["9582001"]}, {"Citation": "Karashima Y, et al. Bimodal action of menthol on the transient receptor potential channel TRPA1. J Neurosci. 2007;27(37):9874\u20139884.", "ArticleIdList": ["PMC6672629", "17855602"]}, {"Citation": "Ghasemi-Pirbaluti M, Motaghi E, Bozorgi H. The effect of menthol on acute experimental colitis in rats. Eur J Pharmacol. 2017;805:101\u2013107.", "ArticleIdList": ["28322843"]}, {"Citation": "Perraud A-L, Knowles H, Schmitz C. Novel aspects of signaling and ion-homeostasis regulation in immunocytes: the TRPM ion channels and their potential role in modulating the immune response. Mol Immunol. 2004;41(6\u20137):657\u2013673.", "ArticleIdList": ["15220002"]}, {"Citation": "Ramachandran R, et al. TRPM8 activation attenuates inflammatory responses in mouse models of colitis. Proc Natl Acad Sci. 2013;110(18):7476\u20137481.", "ArticleIdList": ["PMC3645521", "23596210"]}, {"Citation": "L\u00fc JM, et al. Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med. 2010;14(4):840\u2013860.", "ArticleIdList": ["PMC2927345", "19754673"]}, {"Citation": "Nejatzadeh-Barandozi F. Antibacterial activities and antioxidant capacity of Aloe vera. Org Med Chem Lett. 2013;3(1):5.", "ArticleIdList": ["PMC3729540", "23870710"]}, {"Citation": "Rodriguez TS, Gim\u00e9nez DG, De la Puerta V\u00e1zquez R. Choleretic activity and biliary elimination of lipids and bile acids induced by an artichoke leaf extract in rats. Phytomedicine. 2002;9(8):687\u2013693.", "ArticleIdList": ["12587687"]}, {"Citation": "Wegener T, Fintelmann V. Pharmacological properties and therapeutic profile of artichoke (Cynara scolymus L.) Wien Med Wochenschr (1946) 1999;149(8\u201310):241\u2013247.", "ArticleIdList": ["10483691"]}, {"Citation": "Emendorfer F, et al. Evaluation of the relaxant action of some Brazilian medicinal plants in isolated Guinea-pig ileum and rat duodenum. J Pharm Pharm Sci. 2005;8(1):63\u201368.", "ArticleIdList": ["15946599"]}, {"Citation": "Asif M. Phytochemical study of polyphenols in Perilla Frutescens as an antioxidant. Avicenna J Phytomed. 2012;2(4):169.", "ArticleIdList": ["PMC4075683", "25050247"]}, {"Citation": "Rahimi R, Abdollahi M. Herbal medicines for the management of irritable bowel syndrome: a comprehensive review. World J Gastroenterol: WJG. 2012;18(7):589.", "ArticleIdList": ["PMC3281215", "22363129"]}, {"Citation": "Corazziari E, et al. Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2003;18(6):569\u2013580.", "ArticleIdList": ["12969083"]}, {"Citation": "Tian J, et al. Regional variation in components and antioxidant and antifungal activities of Perilla frutescens essential oils in China. Ind Crop Prod. 2014;59:69\u201379."}, {"Citation": "Verspohl EJ, et al. Testing of Perilla frutescens extract and Vicenin 2 for their antispasmodic effect. Phytomedicine. 2013;20(5):427\u2013431.", "ArticleIdList": ["23357362"]}, {"Citation": "Buchwald-Werner S, et al. Perilla extract improves gastrointestinal discomfort in a randomized placebo controlled double blind human pilot study. BMC Complement Altern Med. 2014;14(1):173.", "ArticleIdList": ["PMC4038823", "24885816"]}, {"Citation": "Yang F, et al. The green tea polyphenol (\u2212)-epigallocatechin-3-gallate blocks nuclear factor-\u03baB activation by inhibiting I\u03baB kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol. 2001;60(3):528\u2013533.", "ArticleIdList": ["11502884"]}, {"Citation": "Walker AF, Middleton RW, Petrowicz O. Artichoke leaf extract reduces symptoms of irritable bowel syndrome in a post-marketing surveillance study. Phytother Res. 2001;15(1):58\u201361.", "ArticleIdList": ["11180525"]}, {"Citation": "Bundy R, et al. Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia: a subset analysis. J Altern Complement Med. 2004;10(4):667\u2013669.", "ArticleIdList": ["15353023"]}, {"Citation": "Nanjo F, et al. Scavenging effects of tea catechins and their derivatives on 1, 1-diphenyl-2-picrylhydrazyl radical. Free Radic Biol Med. 1996;21(6):895\u2013902.", "ArticleIdList": ["8902534"]}, {"Citation": "Khokhar S, Magnusdottir S. Total phenol, catechin, and caffeine contents of teas commonly consumed in the United Kingdom. J Agric Food Chem. 2002;50(3):565\u2013570.", "ArticleIdList": ["11804530"]}, {"Citation": "Jeong JH, et al. Epigallocatechin 3-gallate attenuates neuronal damage induced by 3-hydroxykynurenine. Toxicology. 2004;195(1):53\u201360.", "ArticleIdList": ["14698567"]}, {"Citation": "Levites Y, et al. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-\u03baB) activation and cell death by tea extracts in neuronal cultures1. Biochem Pharmacol. 2002;63(1):21\u20139.", "ArticleIdList": ["11754870"]}, {"Citation": "Lin Y-L, Lin J-K. (\u2212)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-\u03baB. Mol Pharmacol. 1997;52(3):465\u2013472.", "ArticleIdList": ["9281609"]}, {"Citation": "Levites Y, et al. Green tea polyphenol (\u2212)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem. 2001;78(5):1073\u20131082.", "ArticleIdList": ["11553681"]}, {"Citation": "Barthelman M, et al. (\u2212)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity. Carcinogenesis. 1998;19(12):2201\u20132204.", "ArticleIdList": ["9886579"]}, {"Citation": "Wheeler DS, et al. Epigallocatechin-3-gallate, a green tea\u2013derived polyphenol, inhibits IL-1\u03b2-dependent proinflammatory signal transduction in cultured respiratory epithelial cells. J Nutr. 2004;134(5):1039\u20131044.", "ArticleIdList": ["15113942"]}, {"Citation": "Veres, B., Anti-inflammatory role of natural polyphenols and their degradation products, in Severe Sepsis and Septic Shock-Understanding a Serious Killer 2012. InTech."}, {"Citation": "Shin H-Y, et al. Epigallocatechin-3-gallate inhibits secretion of TNF-\u03b1, IL-6 and IL-8 through the attenuation of ERK and NF-\u03baB in HMC-1 cells. Int Arch Allergy Immunol. 2007;142(4):335\u2013344.", "ArticleIdList": ["17135765"]}, {"Citation": "Youn Hyung S., Lee Joo Y., Saitoh Shin I., Miyake Kensuke, Kang Keon W., Choi Yong J., Hwang Daniel H. Suppression of MyD88- and TRIF-dependent signaling pathways of toll-like receptor by (\u2212)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochemical Pharmacology. 2006;72(7):850\u2013859.", "ArticleIdList": ["16890209"]}, {"Citation": "Osuchowski MF, et al. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol. 2006;177(3):1967\u20131974.", "ArticleIdList": ["16849510"]}, {"Citation": "Li W, et al. A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1. PLoS One. 2007;2(11):e1153.", "ArticleIdList": ["PMC2048740", "17987129"]}, {"Citation": "Heuer JG, et al. Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis. Crit Care Med. 2004;32(7):1570\u20131578.", "ArticleIdList": ["15241104"]}, {"Citation": "Bae H-B, et al. The effect of epigallocatechin gallate on lipopolysaccharide-induced acute lung injury in a murine model. Inflammation. 2010;33(2):82\u201391.", "ArticleIdList": ["19838780"]}, {"Citation": "Yun H-J, et al. Epigallocatechin-3-gallate suppresses TNF-\u03b1-induced production of MMP-1 and-3 in rheumatoid arthritis synovial fibroblasts. Rheumatol Int. 2008;29(1):23\u201329.", "ArticleIdList": ["18496696"]}, {"Citation": "Ichikawa D, et al. Effect of various catechins on the IL-12p40 production by murine peritoneal macrophages and a macrophage cell line, J774. 1. Biol Pharm Bull. 2004;27(9):1353\u20131358.", "ArticleIdList": ["15340218"]}, {"Citation": "Ouyang P, et al. Green tea polyphenols inhibit advanced glycation end product-induced rat vascular smooth muscle cell proliferation. Di Yi Jun Yi Da Xue Xue Bao. 2004;24(3):247\u2013251.", "ArticleIdList": ["15041533"]}, {"Citation": "Dekdouk, N., et al., Phenolic compounds from Olea europaea L. possess antioxidant activity and inhibit carbohydrate metabolizing enzymes in vitro. Evid Based Complement Alternat Med, 2015. 2015.", "ArticleIdList": ["PMC4618337", "26557862"]}, {"Citation": "Mart\u00edn-Pel\u00e1ez S, et al. Influence of phenol-enriched olive oils on human intestinal immune function. Nutrients. 2016;8(4):213.", "ArticleIdList": ["PMC4848682", "27077879"]}, {"Citation": "Koca U, et al. Wound repair potential of Olea europaea L. leaf extracts revealed by in vivo experimental models and comparative evaluation of the extracts' antioxidant activity. J Med Food. 2011;14(1\u20132):140\u2013146.", "ArticleIdList": ["21128831"]}, {"Citation": "Larussa T, et al. Oleuropein decreases cyclooxygenase-2 and interleukin-17 expression and attenuates inflammatory damage in colonic samples from ulcerative colitis patients. Nutrients. 2017;9(4):391.", "ArticleIdList": ["PMC5409730", "28420140"]}, {"Citation": "Jang M, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275(5297):218\u2013220.", "ArticleIdList": ["8985016"]}, {"Citation": "Virgili M, Contestabile A. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci Lett. 2000;281(2\u20133):123\u2013126.", "ArticleIdList": ["10704758"]}, {"Citation": "Xu Y, et al. Trans-resveratrol ameliorates stress-induced irritable bowel syndrome-like behaviors by regulation of brain-gut axis. Front Pharmacol. 2018;9:631.", "ArticleIdList": ["PMC6013570", "29962949"]}, {"Citation": "Hung L-M, et al. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res. 2000;47(3):549\u2013555.", "ArticleIdList": ["10963727"]}, {"Citation": "Chung JH. Metabolic benefits of inhibiting cAMP-PDEs with resveratrol. Adipocyte. 2012;1(4):256\u2013258.", "ArticleIdList": ["PMC3609109", "23700542"]}, {"Citation": "Dami\u00e1n JP, et al. Effect of resveratrol on behavioral Performanceof Streptozotocin-induced diabetic mice inAnxiety tests. Exp Anim. 2014;63(3):277\u2013287.", "ArticleIdList": ["PMC4206731", "25077757"]}, {"Citation": "Ge J-F, et al. Resveratrol ameliorates the anxiety-and depression-like behavior of subclinical hypothyroidism rat: possible involvement of the HPT axis, HPA axis, and Wnt/\u03b2-catenin pathway. Front Endocrinol. 2016;7:44.", "ArticleIdList": ["PMC4877500", "27252679"]}, {"Citation": "Ali SH, et al. Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice. Steroids. 2015;101:37\u201342.", "ArticleIdList": ["26048446"]}, {"Citation": "Wang X, et al. Resveratrol reverses chronic restraint stress-induced depression-like behaviour: involvement of BDNF level, ERK phosphorylation and expression of Bcl-2 and Bax in rats. Brain Res Bull. 2016;125:134\u2013143.", "ArticleIdList": ["27346276"]}, {"Citation": "Wang N, et al. Resveratrol protects oxidative stress-induced intestinal epithelial barrier dysfunction by upregulating heme oxygenase-1 expression. Dig Dis Sci. 2016;61(9):2522\u20132534.", "ArticleIdList": ["27146412"]}, {"Citation": "Wang G, et al. The effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signaling. Oncotarget. 2016;7(14):17380.", "ArticleIdList": ["PMC4951219", "26980711"]}, {"Citation": "Barnette MS, et al. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle. J Pharmacol Exp Ther. 1993;264(2):801\u2013812.", "ArticleIdList": ["7679736"]}, {"Citation": "Johansson EM, Reyes-Irisarri E, Mengod G. Comparison of cAMP-specific phosphodiesterase mRNAs distribution in mouse and rat brain. Neurosci Lett. 2012;525(1):1\u20136.", "ArticleIdList": ["22884617"]}, {"Citation": "Barone FC, et al. Inhibition of phosphodiesterase type 4 decreases stress-induced defecation in rats and mice. Pharmacology. 2008;81(1):11\u201317.", "ArticleIdList": ["17726343"]}, {"Citation": "Birrell MA, et al. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-\u03baB-independent mechanism. FASEB J. 2005;19(7):840\u2013841.", "ArticleIdList": ["15734790"]}, {"Citation": "Chung EK, et al. Neonatal maternal separation enhances central sensitivity to noxious colorectal distention in rat. Brain Res. 2007;1153:68\u201377.", "ArticleIdList": ["17434464"]}, {"Citation": "Belguendouz L, Fr\u00e9mont L, Gozzelino M-T. Interaction of transresveratrol with plasma lipoproteins. Biochem Pharmacol. 1998;55(6):811\u2013816.", "ArticleIdList": ["9586953"]}, {"Citation": "Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-\u03baB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol. 2000;164(12):6509\u20136519.", "ArticleIdList": ["10843709"]}, {"Citation": "Surh Y-J, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-\u03baB activation. Mutat Res. 2001;480:243\u2013268.", "ArticleIdList": ["11506818"]}, {"Citation": "Chan MM-Y, et al. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem Pharmacol. 2000;60(10):1539\u20131548.", "ArticleIdList": ["11020457"]}, {"Citation": "Martinez J, Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol. 2000;59(7):865\u2013870.", "ArticleIdList": ["10718345"]}, {"Citation": "Moreno JJ. Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth. J Pharmacol Exp Ther. 2000;294(1):333\u2013338.", "ArticleIdList": ["10871330"]}, {"Citation": "Martin AR, et al. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem Pharmacol. 2004;67(7):1399\u20131410.", "ArticleIdList": ["15013856"]}, {"Citation": "Tsai SH, Lin-Shiau SY, Lin JK. Suppression of nitric oxide synthase and the down-regulation of the activation of NF\u03baB in macrophages by resveratrol. Br J Pharmacol. 1999;126(3):673\u2013680.", "ArticleIdList": ["PMC1565862", "10188978"]}, {"Citation": "Wadsworth TL, Koop DR. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol. 1999;57(8):941\u2013949.", "ArticleIdList": ["10086329"]}, {"Citation": "Kruidenier L., Verspaget H. W. Oxidative stress as a pathogenic factor in inflammatory bowel disease - radicals or ridiculous? Alimentary Pharmacology and Therapeutics. 2002;16(12):1997\u20132015.", "ArticleIdList": ["12452933"]}, {"Citation": "Nitta M, et al. Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329. Scand J Immunol. 2002;56(1):66\u201375.", "ArticleIdList": ["12100473"]}, {"Citation": "Abreu MT. The pathogenesis of inflammatory bowel disease: translational implications for clinicians. Curr Gastroenterol Rep. 2002;4(6):481\u2013489.", "ArticleIdList": ["12441038"]}, {"Citation": "Siegmund B. Interleukin-1\u03b2 converting enzyme (caspase-1) in intestinal inflammation. Biochem Pharmacol. 2002;64(1):1\u20138.", "ArticleIdList": ["12106600"]}, {"Citation": "Zhong W, et al. Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. Immunology. 1995;84(3):446.", "ArticleIdList": ["PMC1415127", "7751029"]}, {"Citation": "Gonzales AM, Orlando RA. Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab. 2008;5(1):17.", "ArticleIdList": ["PMC2441623", "18549505"]}, {"Citation": "Gao X, et al. Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production1. Biochem Pharmacol. 2001;62(9):1299\u20131308.", "ArticleIdList": ["11705464"]}, {"Citation": "Ajuebor MN, Singh A, Wallace JL. Cyclooxygenase-2-derived prostaglandin D2 is an early anti-inflammatory signal in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2000;279(1):G238\u2013G244.", "ArticleIdList": ["10898767"]}, {"Citation": "S\u00e1nchez-Fidalgo S, et al. Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur J Pharmacol. 2010;633(1\u20133):78\u201384.", "ArticleIdList": ["20132809"]}, {"Citation": "Culpitt S, et al. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax. 2003;58(11):942\u2013946.", "ArticleIdList": ["PMC1746526", "14586044"]}, {"Citation": "Das S, Das DK. Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets. 2007;6(3):168\u2013173.", "ArticleIdList": ["17897053"]}, {"Citation": "Holmes-McNary M, Baldwin AS. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the I\u03baB kinase. Cancer Res. 2000;60(13):3477\u20133483.", "ArticleIdList": ["10910059"]}, {"Citation": "Jiang Z, et al. Toll-like receptor 3-mediated activation of NF-\u03baB and IRF3 diverges at toll-IL-1 receptor domain-containing adapter inducing IFN-\u03b2. Proc Natl Acad Sci. 2004;101(10):3533\u20133538.", "ArticleIdList": ["PMC373497", "14982987"]}, {"Citation": "Youn HS, et al. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol. 2005;175(5):3339\u20133346.", "ArticleIdList": ["16116226"]}, {"Citation": "Kundu JK, et al. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-\u03baB in mouse skin by blocking I\u03baB kinase activity. Carcinogenesis. 2006;27(7):1465\u20131474.", "ArticleIdList": ["16474181"]}, {"Citation": "Bar-Sela G, Epelbaum R, Schaffer M. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem. 2010;17(3):190\u2013197.", "ArticleIdList": ["20214562"]}, {"Citation": "Mills, S. and K. Bone, Principles and practice of phytotherapy. Modern herbal medicine 2000: Churchill Livingstone."}, {"Citation": "Holt PR, Katz S, Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci. 2005;50(11):2191\u20132193.", "ArticleIdList": ["16240238"]}, {"Citation": "Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23(1/A):363\u2013398.", "ArticleIdList": ["12680238"]}, {"Citation": "Liu Z, et al. Curcumin upregulates Nrf2 nuclear translocation and protects rat hepatic stellate cells against oxidative stress. Mol Med Rep. 2016;13(2):1717\u20131724.", "ArticleIdList": ["26676408"]}, {"Citation": "Biswas SK, et al. Curcumin induces glutathione biosynthesis and inhibits NF-\u03baB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal. 2005;7(1\u20132):32\u201341.", "ArticleIdList": ["15650394"]}, {"Citation": "Jin CY, et al. Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia 1. Acta Pharmacol Sin. 2007;28(10):1645\u20131651.", "ArticleIdList": ["17883952"]}, {"Citation": "Ak T, G\u00fcl\u00e7in \u0130. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact. 2008;174(1):27\u201337.", "ArticleIdList": ["18547552"]}, {"Citation": "ABE Y, Hashimoto S, HORIE T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res. 1999;39(1):41\u201347.", "ArticleIdList": ["10051376"]}, {"Citation": "Ghanaatian N, et al. Curcumin as a therapeutic candidate for multiple sclerosis: molecular mechanisms and targets. J Cell Physiol. 2018.", "ArticleIdList": ["30536381"]}, {"Citation": "Chan MM-Y. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol. 1995;49(11):1551\u20131556.", "ArticleIdList": ["7786295"]}, {"Citation": "Banerjee M, et al. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol. 2003;25(2):213\u2013224.", "ArticleIdList": ["12784914"]}, {"Citation": "Gukovsky I, et al. Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2003;284(1):G85\u2013G95.", "ArticleIdList": ["12488237"]}, {"Citation": "Kaur G, et al. Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents. Clin Exp Immunol. 2006;145(2):313\u2013321.", "ArticleIdList": ["PMC1809677", "16879252"]}, {"Citation": "Heitkemper MM, et al. Symptoms across the menstrual cycle in women with irritable bowel syndrome. Am J Gastroenterol. 2003;98(2):420.", "ArticleIdList": ["12591063"]}, {"Citation": "Smith YR, et al. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci. 2006;26(21):5777\u20135785.", "ArticleIdList": ["PMC1808228", "16723535"]}, {"Citation": "Braniste V, et al. Oestradiol decreases colonic permeability through oestrogen receptor \u03b2-mediated up-regulation of occludin and junctional adhesion molecule-a in epithelial cells. J Physiol. 2009;587(13):3317\u20133328.", "ArticleIdList": ["PMC2727039", "19433574"]}, {"Citation": "Morito K, et al. Interaction of phytoestrogens with estrogen receptors \u03b1 and \u03b2. Biol Pharm Bull. 2001;24(4):351\u2013356.", "ArticleIdList": ["11305594"]}, {"Citation": "Seo HS, et al. Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-\u03baB signaling in HER2-overexpressing breast cancer cells. Anticancer Res. 2011;31(10):3301\u20133313.", "ArticleIdList": ["21965740"]}, {"Citation": "Li Z, et al. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol in Vitro. 2008;22(7):1749\u20131753.", "ArticleIdList": ["18761399"]}, {"Citation": "Pan H, et al. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-\u03baB activity via the Notch-1 pathway. Int J Mol Med. 2012;30(2):337\u2013343.", "ArticleIdList": ["22580499"]}, {"Citation": "Polivka J., Jr And F. Janku, Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol Ther. 2014;142(2):164\u2013175.", "ArticleIdList": ["24333502"]}, {"Citation": "Gil EMC. Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer. Cancer Treat Rev. 2014;40(7):862\u2013871.", "ArticleIdList": ["24774538"]}, {"Citation": "Chen J, et al. Genistein induces apoptosis by the inactivation of the IGF-1R/p-Akt signaling pathway in MCF-7 human breast cancer cells. Food Funct. 2015;6(3):995\u20131000.", "ArticleIdList": ["25675448"]}, {"Citation": "Ahmad A, et al. Deregulation of PI3K/Akt/mTOR signaling pathways by isoflavones and its implication in cancer treatment. Anti Cancer Agents Med Chem. 2013;13(7):1014\u20131024.", "ArticleIdList": ["23272911"]}, {"Citation": "Huang X, et al. Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma. Am J Pathol. 2012;181(1):26\u201333.", "ArticleIdList": ["PMC3388146", "22609116"]}, {"Citation": "Shim H-Y, et al. Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain\u2013caspase and apoptosis signaling kinase 1\u2013p38 mitogen-activated protein kinase activation cascades. Anti-Cancer Drugs. 2007;18(6):649\u2013657.", "ArticleIdList": ["17762393"]}, {"Citation": "Liu H, et al. Delayed activation of extracellular-signal-regulated kinase 1/2 is involved in genistein-and equol-induced cell proliferation and estrogen-receptor-\u03b1-mediated transcription in MCF-7 breast cancer cells. J Nutr Biochem. 2010;21(5):390\u2013396.", "ArticleIdList": ["19427779"]}, {"Citation": "Yang X, et al. Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER\u2013erbB-2 cross talk and p27/kip1 downregulation. Carcinogenesis. 2010;31(4):695\u2013702.", "ArticleIdList": ["20067990"]}, {"Citation": "Uif\u0103lean A, et al. Soy isoflavones and breast cancer cell lines: molecular mechanisms and future perspectives. Molecules. 2015;21(1):13.", "ArticleIdList": ["PMC6273223", "26703550"]}, {"Citation": "Mencalha A, et al. Mapping oxidative changes in breast cancer: understanding the basic to reach the clinics. Anticancer Res. 2014;34(3):1127\u20131140.", "ArticleIdList": ["24596350"]}, {"Citation": "Sastre-Serra J, et al. Estrogen down-regulates uncoupling proteins and increases oxidative stress in breast cancer. Free Radic Biol Med. 2010;48(4):506\u2013512.", "ArticleIdList": ["19969066"]}, {"Citation": "Pons DG, et al. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio. J Cell Biochem. 2014;115(5):949\u2013958.", "ArticleIdList": ["24375531"]}, {"Citation": "Nadal-Serrano M, et al. The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17Beta-estradiol. J Cell Biochem. 2012;113(10):3178\u20133185.", "ArticleIdList": ["22615145"]}, {"Citation": "Prietsch R, et al. Genistein induces apoptosis and autophagy in human breast MCF-7 cells by modulating the expression of proapoptotic factors and oxidative stress enzymes. Mol Cell Biochem. 2014;390(1\u20132):235\u2013242.", "ArticleIdList": ["24573886"]}, {"Citation": "Ullah MF, et al. Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen species. Mol Nutr Food Res. 2011;55(4):553\u2013559.", "ArticleIdList": ["21462322"]}, {"Citation": "Leung HY, et al. Genistein protects against polycyclic aromatic hydrocarbon-induced oxidative DNA damage in non-cancerous breast cells MCF-10A. Br J Nutr. 2008;101(2):257\u2013262.", "ArticleIdList": ["18570695"]}, {"Citation": "Choi JN, et al. 2\u2032-hydroxylation of genistein enhanced antioxidant and antiproliferative activities in mcf-7 human breast cancer cells. J Microbiol Biotechnol. 2009;19(11):1348\u20131354.", "ArticleIdList": ["19996686"]}, {"Citation": "Lee Y-M, et al. Dietary anthocyanins against obesity and inflammation. Nutrients. 2017;9(10):1089.", "ArticleIdList": ["PMC5691706", "28974032"]}, {"Citation": "Neyrinck AM, et al. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota. Br J Nutr. 2013;109(5):802\u2013809.", "ArticleIdList": ["22676910"]}, {"Citation": "Lu Y-C, Yeh W-C, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008;42(2):145\u2013151.", "ArticleIdList": ["18304834"]}, {"Citation": "Moreira APB, et al. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr. 2012;108(5):801\u2013809.", "ArticleIdList": ["22717075"]}, {"Citation": "Takeda, K. and S. Akira. TLR signaling pathways. In Seminars in immunology. 2004. Elsevier.", "ArticleIdList": ["14751757"]}, {"Citation": "Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783\u2013801.", "ArticleIdList": ["16497588"]}, {"Citation": "Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun. 2009;388(4):621\u2013625.", "ArticleIdList": ["19686699"]}, {"Citation": "Rodes L, et al. Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. J Microbiol Biotechnol. 2013;23(4):518\u2013526.", "ArticleIdList": ["23568206"]}, {"Citation": "Villena J, Kitazawa H. Modulation of intestinal TLR4-inflammatory signaling pathways by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937. Front Immunol. 2014;4:512.", "ArticleIdList": ["PMC3890654", "24459463"]}, {"Citation": "Li Y, et al. Quercetin, inflammation and immunity. Nutrients. 2016;8(3):167.", "ArticleIdList": ["PMC4808895", "26999194"]}, {"Citation": "Zhang X-J, et al. Analgesic effect of paeoniflorin in rats with neonatal maternal separation-induced visceral hyperalgesia is mediated through adenosine A1 receptor by inhibiting the extracellular signal-regulated protein kinase (ERK) pathway. Pharmacol Biochem Behav. 2009;94(1):88\u201397.", "ArticleIdList": ["19664651"]}, {"Citation": "Liu, L., et al., The pharmacodynamic study on the effects of antinociception and anti-inflammation of the extracts of Fagopyrum cymosum (Trev.) Meisn. Med Inf, 2012. 25(49): p. 0."}, {"Citation": "Qin H-Y, et al. Quercetin attenuates visceral hypersensitivity and 5-Hydroxytryptamine availability in Postinflammatory irritable bowel syndrome rats: role of Enterochromaffin cells in the Colon. J Med Food. 2019;0(0):1\u20139.", "ArticleIdList": ["30920336"]}, {"Citation": "Qu L, et al. Quercetin alleviates high glucose-induced Schwann cell damage by autophagy. Neural Regen Res. 2014;9(12):1195.", "ArticleIdList": ["PMC4146282", "25206782"]}, {"Citation": "Hanasaki Y, Ogawa S, Fukui S. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic Biol Med. 1994;16(6):845\u2013850.", "ArticleIdList": ["8070690"]}, {"Citation": "Cushnie TT, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agents. 2005;26(5):343\u2013356.", "ArticleIdList": ["PMC7127073", "16323269"]}, {"Citation": "Vanacker SA, et al. Flavonoids as scavengers of nitric oxide radical. Biochem Biophys Res Commun. 1995;214(3):755\u2013759.", "ArticleIdList": ["7575540"]}, {"Citation": "Heijnen CG, et al. Peroxynitrite scavenging of flavonoids: structure activity relationship. Environ Toxicol Pharmacol. 2001;10(4):199\u2013206.", "ArticleIdList": ["21782577"]}, {"Citation": "Ghosh B. Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-\u03b1 production in murine macrophages. Int J Immunopharmacol. 1999;21(7):435\u2013443.", "ArticleIdList": ["10454017"]}, {"Citation": "Gerster R, et al. Anti-inflammatory function of high-density lipoproteins via autophagy of IkappaB kinase. Cell Mol Gastroenterol Hepatol. 2015;1(2):171\u2013187.", "ArticleIdList": ["PMC5301135", "28247863"]}, {"Citation": "Bureau G, Longpr\u00e9 F, Martinoli MG. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J Neurosci Res. 2008;86(2):403\u2013410.", "ArticleIdList": ["17929310"]}, {"Citation": "Nair MP, et al. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-\u03ba\u03b2 system. Clin Vaccine Immunol. 2006;13(3):319\u2013328.", "ArticleIdList": ["PMC1391952", "16522772"]}, {"Citation": "Cho S-Y, et al. Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-\u03baB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem. 2003;243(1\u20132):153\u2013160.", "ArticleIdList": ["12619901"]}, {"Citation": "Kempuraj D, et al. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol. 2005;145(7):934\u2013944.", "ArticleIdList": ["PMC1576204", "15912140"]}, {"Citation": "Kobuchi H, et al. Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem Pharmacol. 1997;53(6):897\u2013903.", "ArticleIdList": ["9113109"]}, {"Citation": "Zhou Yue, Zheng Jie, Li Ya, Xu Dong-Ping, Li Sha, Chen Yu-Ming, Li Hua-Bin. Natural Polyphenols for Prevention and Treatment of Cancer. Nutrients. 2016;8(8):515.", "ArticleIdList": ["PMC4997428", "27556486"]}, {"Citation": "Gormaz JG, et al. Potential role of polyphenols in the prevention of cardiovascular diseases: molecular bases. Curr Med Chem. 2016;23(2):115\u201328.", "ArticleIdList": ["26630919"]}, {"Citation": "Bahadoran Z, Mirmiran P, Azizi F. Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord. 2013;12(1):43.", "ArticleIdList": ["PMC7968452", "23938049"]}, {"Citation": "Karunaweera N, et al. Plant polyphenols as inhibitors of NF-\u03baB induced cytokine production\u2014a potential anti-inflammatory treatment for Alzheimer's disease? Front Mol Neurosci. 2015;8:24.", "ArticleIdList": ["PMC4468843", "26136655"]}, {"Citation": "Martin DA, Bolling BW. A review of the efficacy of dietary polyphenols in experimental models of inflammatory bowel diseases. Food Funct. 2015;6(6):1773\u20131786.", "ArticleIdList": ["25986932"]}]}], "History": [{"Year": "2019", "Month": "3", "Day": "30"}, {"Year": "2019", "Month": "6", "Day": "14"}, {"Year": "2019", "Month": "7", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "4"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31273572", "PMC6895345", "10.1007/s40199-019-00284-1", "10.1007/s40199-019-00284-1"]}}]}